Autologous Stem Cell Transplantation as a Care Option in Waldenstrom's Macroglobulinemia
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2011)
Journal
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Volume 11, Issue 1, Pages 139-142Publisher
CIG MEDIA GROUP, LP
Keywords
Categories
Ask authors/readers for more resources
Authors
I am an author on this paper
Reviews
Recommended
BeEAM Conditioning including High-Dose Bendamustine before Autologous Stem Cell Transplantation Is Safe and Effective in Patients with Waldenstrom's Macroglobulinemia
Alexander D. Heini, Philipp Beck, Ulrike Bacher, Katja Seipel, Thilo Zander, Michael Daskalakis, Thomas Pabst
JOURNAL OF CLINICAL MEDICINE (2023)
Rituximab as a Treatment Option after Autologous Hematopoietic Stem Cell Transplantation in a Patient with Systemic Sclerosis
Paul Gressenberger, Philipp Jud, Gabor Kovacs, Sonja Kreuzer, Hans-Peter Brezinsek, Katharina Guetl, Viktoria Muster, Ewald Kolesnik, Albrecht Schmidt, Balazs Odler, Gabriel Adelsmayr, Peter Neumeister, Luka Brcic, Sabine Zenz, Kurt Weber, Thomas Gary, Marianne Brodmann, Winfried B. Graninger, Florentine C. Moazedi-Fuerst
JOURNAL OF PERSONALIZED MEDICINE (2021)
Diagnostics in Waldenstrom's macroglobulinemia: a consensus statement of the European Consortium for Waldenstrom's Macroglobulinemia
Irene Dogliotti, Cristina Jimenez, Marzia Varettoni, Dipti Talaulikar, Tina Bagratuni, Martina Ferrante, Jose Perez, Daniela Drandi, Noemi Puig, Milena Gilestro, Maria Garcia-Alvarez, Roger Owen, Wojciech Jurczak, Alessandra Tedeschi, Veronique Leblond, Efstathios Kastritis, Marie Jose Kersten, Shirley D'Sa, Michal Kascak, Wolfgang Willenbacher, Aldo M. Roccaro, Stephanie Poulain, Pierre Morel, Charalampia Kyriakou, Falko Fend, Josephine M. Vos, Meletios A. Dimopoulos, Christian Buske, Simone Ferrero, Ramon Garcia-Sanz
LEUKEMIA (2022)
Single-cell transcriptome analysis reveals stem cell-like subsets in the progression of Waldenstrom's macroglobulinemia
Yu Qiu, Xiao-shuang Wang, Yuan Yao, Yan-min Si, Xue-zhu Wang, Ming-nan Jia, Dao-bin Zhou, Jia Yu, Xin-xin Cao, Jian Li
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2023)
Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenstrom's Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenstrom's Macroglobulinemia
Christian Buske, Meletios A. Dimopoulos, Alexander Grunenberg, Efstathios Kastritis, Cecile Tomowiak, Beatrice Mahe, Xavier Troussard, Roman Hajek, Andreas Viardot, Olivier Tournilhac, Therese Aurran, Stephane Lepretre, Hacene Zerazhi, Benedicte Hivert, Veronique Leblond, Sophie de Guibert, Lena Brandefors, Ramon Garcia-Sanz, Maria Gomes da Silva, Eva Kimby, Birgit Schmelzle, Dajana Kaszynski, Jens Dreyhaupt, Rainer Muche, Pierre Morel
JOURNAL OF CLINICAL ONCOLOGY (2023)
Autologous Stem Cell Transplantation for Myeloma: Cytoreduction or an Immunotherapy?
Simone A. Minnie, Geoffrey R. Hill
FRONTIERS IN IMMUNOLOGY (2021)
MicroRNA-125b as a valuable predictive marker for outcome after autologous hematopoietic stem cell transplantation
Mohammad Rafiee, Fatemeh Amiri, Mohammad Hossein Mohammadi, Abbas Hajifathali
BMC CANCER (2023)
Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
Lakshmi Yarlagadda, Sravani Gundarlapalli, Richa Parikh, Reid D. Landes, Mathew Kottarathara, Yetunde Ogunsesan, Shadiqul Hoque, Angel A. Mitma, Clyde Bailey, Kerri M. Hill, Sharmilan Thanendrarajan, Monica Graziutti, Meera Mohan, Maurizio Zangari, Frits van Rhee, Guido Tricot, Carolina Schinke
CANCERS (2021)
Autologous haematopoietic stem cell transplantation for refractory stiff-person syndrome: the UK experience
Lewis Kass-Iliyya, John A. Snowden, Alice Thorpe, Helen Jessop, Andrew D. Chantry, Ptolemaios G. Sarrigiannis, Marios Hadjivassiliou, Basil Sharrack
JOURNAL OF NEUROLOGY (2021)
Microfluidic processing of stem cells for autologous cell replacement
Nicholas E. Stone, Andrew P. Voigt, Robert F. Mullins, Todd Sulchek, Budd A. Tucker
STEM CELLS TRANSLATIONAL MEDICINE (2021)
Busulfan, etoposide, cytarabine, and melphalan as a high-dose regimen for autologous stem cell transplantation in peripheral T-cell lymphomas
Jae-Cheol Jo, Jin-Seok Kim, Je-Hwan Lee, Jung-Hee Lee, Seong Nam Im, Sang-Min Lee, Sung-Soo Yoon, In-Ho Kim, Seong Hwa Bae, Yoo Jin Lee, Yunsuk Choi, Won-Sik Lee
ANNALS OF HEMATOLOGY (2021)
Patient preferences regarding treatment options for Waldenstrom's macroglobulinemia: A discrete choice experiment
Karima Amaador, Pythia T. Nieuwkerk, Monique C. Minnema, Marie Jose Kersten, Josephine M. Vos
CANCER MEDICINE (2023)
First-Line Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: A Systematic Analysis and Treatment Recommendation
Hailing Liu, Xiao Shi, Huizi Fang, Lei Cao, Yi Miao, Xiaoli Zhao, Wei Wu, Wei Xu, Jianyong Li, Lei Fan
FRONTIERS IN ONCOLOGY (2022)
Autologous Stem Cell Transplantation in the Treatment of Pulmonary Light Chain Deposition Disease
Matthew Rendo, Teri J. Franks, Jeffrey R. Galvin, Andrew Berglund, Charles Volk, Matthew Peterson
CHEST (2021)
Optimizing autologous hematopoietic stem cell transplantation for acute leukemia
Aiming Pang, Yingying Huo, Biao Shen, Yawei Zheng, Erlie Jiang, Sizhou Feng, Mingzhe Han
STEM CELLS TRANSLATIONAL MEDICINE (2021)
Comparison of Cilta-cel, an Anti-BCMA CAR-T Cell Therapy, Versus Conventional Treatment in Patients With Relapsed/Refractory Multiple Myeloma
Luciano J. Costa, Yi Lin, R. Frank Cornell, Thomas Martin, Saurabh Chhabra, Saad Z. Usmani, Sundar Jagannath, Natalie S. Callander, Jesus G. Berdeja, Yubin Kang, Ravi Vij, Kelly N. Godby, Ehsan Malek, Amarendra Neppalli, Michaela Liedtke, Mark Fiala, Hong Tian, Satish Valluri, Jennifer Marino, Carolyn C. Jackson, Arnob Banerjee, Ankit Kansagra, Jordan M. Schecter, Shaji Kumar, Parameswaran Hari
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2022)
Meta-analysis of ciltacabtagene autoleucel versus physician's choice therapy for the treatment of patients with relapsed or refractory multiple myeloma
Luciano J. Costa, Parameswaran Hari, Jesus G. Berdeja, Valerio De Stefano, Francesca Gay, Becky Hooper, Meaghan Bartlett, Anja Haltner, Emily Rosta, Shaji Kumar, Thomas Martin, Maria-Victoria Mateos, Philippe Moreau, Saad Z. Usmani, Yunsi Olyslager, Jordan M. Schecter, Tito Roccia, Ashraf Garrett, Sam Lee, Tonia Nesheiwat, Lida Pacaud, Changwei Zhou, Imtiaz A. Samjoo, Yi Lin, Joris Diels, Satish Valluri, Katja Weisel
CURRENT MEDICAL RESEARCH AND OPINION (2022)
Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up
Thomas Martin, Saad Z. Usmani, Jesus G. Berdeja, Mounzer Agha, Adam D. Cohen, Parameswaran Hari, David Avigan, Abhinav Deol, Myo Htut, Alexander Lesokhin, Nikhil C. Munshi, Elizabeth O'Donnell, A. Keith Stewart, Jordan M. Schecter, Jenna D. Goldberg, Carolyn C. Jackson, Tzu-Min Yeh, Arnob Banerjee, Alicia Allred, Enrique Zudaire, William Deraedt, Yunsi Olyslager, Changwei Zhou, Lida Pacaud, Deepu Madduri, Andrzej Jakubowiak, Yi Lin, Sundar Jagannath
JOURNAL OF CLINICAL ONCOLOGY (2023)
Standardizing Clinical Workflow for Assessing Minimal Residual Disease by Flow Cytometry in Multiple Myeloma
David M. Foureau, Barry A. Paul, Fei Guo, Edward H. Lipford, Kateryna Fesenkova, Elise Tjaden, Kendra Drummond, Manisha Bhutani, Shebli Atrash, Ami Ndiaye, Cindy Varga, Peter M. Voorhees, Saad Z. Usmani
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2023)
Patient Perceptions Regarding Ciltacabtagene Autoleucel Treatment: Qualitative Evidence From Interviews With Patients With Relapsed/Refractory Multiple Myeloma in the CARTITUDE-1 Study
Adam D. Cohen, Parameswaran Hari, Myo Htut, Jesus G. Berdeja, Saad Z. Usmani, Deepu Madduri, Yunsi Olyslager, Jenna D. Goldberg, Jordan M. Schecter, Carolyn C. Jackson, Katharine S. Gries, John M. Fastenau, Satish Valluri, William Deraedt, Muhammad Akram, Rebecca Crawford, Ross Morrison, Lynda Doward, Kate Morgan, Silene ten Seldam, Andrzej Jakubowiak, Sundar Jagannath
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2023)
Updated results from a matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma
Tom Martin, Saad Z. Usmani, Jordan M. Schecter, Tito Roccia, Carolyn C. Jackson, William Deraedt, Tzu-Min Yeh, Arnob Banerjee, Lida Pacaud, Ashraf Garrett, Meaghan Bartlett, Anja Haltner, Suzy Van Sanden, Joris Diels, Satish Valluri, Imtiaz A. Samjoo
CURRENT MEDICAL RESEARCH AND OPINION (2023)
Assessment of renal outcome following therapy in monoclonal immunoglobulin deposition disease: Emphasizing the need for a consensus approach
Matthew J. J. Pianko, Timothy Tiutan, Andriy Derkach, Jessica Flynn, Steven P. P. Salvatore, Insara Jaffer-Sathick, Adriana C. C. Rossi, Oscar Lahoud, Malin Hultcrantz, Urvi A. A. Shah, Kylee Maclachlan, David J. J. Chung, Gunjan L. L. Shah, Heather J. J. Landau, Neha Korde, Sham Mailankody, Alexander M. M. Lesokhin, Carlyn Tan, Michael Scordo, Edgar A. A. Jaimes, Sergio A. A. Giralt, Saad Usmani, Hani Hassoun
AMERICAN JOURNAL OF HEMATOLOGY (2023)
Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy
Oliver Van Oekelen, Karthik Nath, Tarek H. Mouhieddine, Tasmin Farzana, Adolfo Aleman, David T. Melnekoff, Yogita Ghodke-Puranik, Gunjan L. Shah, Alexander Lesokhin, Sergio Giralt, Santiago Thibaud, Adriana Rossi, Cesar Rodriguez, Larysa Sanchez, Joshua Richter, Shambavi Richard, Hearn J. Cho, Ajai Chari, Saad Z. Usmani, Sundar Jagannath, Urvi A. Shah, Sham Mailankody, Samir Parekh
BLOOD (2023)
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial
Meletios A. Dimopoulos, Albert Oriol, Hareth Nahi, Jesus San-Miguel, Nizar J. Bahlis, Saad Z. Usmani, Neil Rabin, Robert Z. Orlowski, Kenshi Suzuki, Torben Plesner, Sung-Soo Yoon, Dina Ben Yehuda, Paul G. Richardson, Hartmut Goldschmidt, Donna Reece, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Philippe Moreau
JOURNAL OF CLINICAL ONCOLOGY (2023)
Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab: part 3 of the open-label, multicenter, phase 1b PAVO study
Hareth Nahi, Saad Z. Usmani, Maria-Victoria Mateos, Niels W. C. J. van de Donk, Albert Oriol, Torben Plesner, Nibedita Bandyopadhyay, Peter Hellemans, Brenda Tromp, Ivo Nnane, Donna Zemlickis, Ajai Chari, Philippe Moreau
LEUKEMIA & LYMPHOMA (2023)
Cilta-cel, a BCMA-targeting CAR-T therapy for heavily pretreated patients with relapsed/refractory multiple myeloma
Thomas G. Martin, Deepu Madduri, Lida Pacaud, Saad Z. Usmani
FUTURE ONCOLOGY (2023)
A phase II multi-arm study of magrolimab combinations in patients with relapsed/refractory multiple myeloma
Barry Paul, Michaela Liedtke, Jack Khouri, Robert Rifkin, Mitul D. Gandhi, Andrew Kin, Moshe Y. Levy, Rebecca Silbermann, Francesca Cottini, Douglas W. Sborov, Irwindeep Sandhu, Lyssa Villarreal, Michael Murphy, Lin Gu, Ann Chen, Nishanthan Rajakumaraswamy, Saad Z. Usmani
FUTURE ONCOLOGY (2023)
Addressing the disparities: the approach to the African American patient with multiple myeloma
Manisha Bhutani, Brandon J. Blue, Craig Cole, Ashraf Z. Badros, Saad Z. Usmani, Ajay K. Nooka, Leon Bernal-Mizrachi, Joseph Mikhael
BLOOD CANCER JOURNAL (2023)
Gene interaction network analysis in multiple myeloma detects complex immune dysregulation associated with shorter survival
Anish K. Simhal, Kylee H. Maclachlan, Rena Elkin, Jiening Zhu, Larry Norton, Joseph O. Deasy, Jung Hun Oh, Saad Z. Usmani, Allen Tannenbaum
BLOOD CANCER JOURNAL (2023)
Comparative effectiveness of teclistamab versus real-world treatments for patients with triple-class exposed (TCE), relapsed/refractory multiple myeloma (RRMM).
Amrita Y. Krishnan, Ajay K. Nooka, Ajai Chari, Alfred L. Garfall, Thomas G. Martin, Sandhya Nair, Xiwu Lin, Keqin Qi, Anil Londhe, Lixia Pei, Ammann Eric, Rachel Kobos, Jennifer Smit, Trilok V. Parekh, Mary Slavcev, Saad Zafar Usmani
JOURNAL OF CLINICAL ONCOLOGY (2022)